Pseudolaric Acid B Induces Apoptosis Through p53 and Bax/Bcl-2 Pathways in Human Melanoma A375-S2 Cells |
Gong Xian-Feng
(China-Japan Research Institute of Medical and Pharmaceutical Sciences, Department of Pharmacology, Shen-yang Pharmaceutical University)
Wang Min-Wei (Department of Pharmacology, Shenyang Pharmaceutical university) Tashiro Shin-Ichi (Department of Clinical and Biomedical Sciences, Showa Pharmaceutical university) Onodera Satoshi (Department of Clinical and Biomedical Sciences, Showa Pharmaceutical university) Ikejima Takashi (China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shen-yang Pharmaceutical University) |
1 | Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251 (1993) DOI ScienceOn |
2 | Li, E., Clark, A. M., and Hufford, C. D., Antifungal evaluation of pseudolaric acid B, a major constituent of pseudolarix kaempferi. J. Nat. Prod., 58, 57-67 (1995) DOI ScienceOn |
3 | Pan, D. J., Li, Z. L., Hu, C. Q., Chen, K., Chang, J. J., and Lee, K. H., The cytotoxic principles of Pseudolarix Kaempferi: Pseudolaric acid-A and B and related derivatives. Planta Med., 56, 383-385 (1990) DOI ScienceOn |
4 | Sakahira, H., Enari, M., and Nagata, S., Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature, 391, 96-99 (1998) DOI ScienceOn |
5 | Stewart, N., Hicks, G. G., Paraskevans, F., and Mowat, M., Evidence for a second cell cycle block at /M by p53. Oncogene, 10, 109-115 (1995) |
6 | Taylor, W.R., and Stark, G.R., Regulation of the /M transition by p53. Oncogene, 20, 1803-1815 (2001) DOI ScienceOn |
7 | Yue, T. L., Ohlstein, H. E., and Ruffolo, R. R., Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases. Curr. Opin. Chem. Biol., 3, 474-480 (1999) DOI ScienceOn |
8 | Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S., A., Caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature, 391, 43-50 (1998) DOI PUBMED ScienceOn |
9 | Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., and Lazebnik, Y. A., Identification and inhibition of the ICE/ CED-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43 (1995) DOI ScienceOn |
10 | Kerr, J.F., Wyllie, A.H., and Currie, A.R., Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257 (1972) DOI ScienceOn |
11 | Liu, X. S., Zou, H., Slaughter, C., and Wang, X., DFF, a heterodimeric protein that functions downstream of caspase- 3 to trigger DNA fragmentation during apoptosis. Cell, 89, 175-184 (1997) DOI ScienceOn |
12 | Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C., Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature, 371, 346-347 (1994) DOI ScienceOn |
13 | Agarwal, N. and Mehta, K., Possible involvement of Bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells. Biochem. Biophys. Res. Comm., 230, 251-253 (1997) DOI ScienceOn |
14 | Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R.W., Participation of p53 protein in cellular response to DNA damage. Cancer Res., 51, 6304-6311 (1991) |
15 | Wu, L. X., Xu, J. H., Wu, G. H., and Chen, Y. Z., Inhibitory effect of curcumin on proliferation of K562 cells involves downregulation of -initiated Ras signal transduction pathway. Acta. Pharmacol. Sin., 11, 1155-1160 (2003) |
16 | Mengubas, K., Riordan, F. A., Hoffbrand, V., and Wickremasinghe, G., Co-ordinated downregulation of Bcl-2 and Bax expression during granulocytic and macrophage-like differentiation of the HL60 premyelocytic leukemia cell line. FEBS. Lett., 394, 356-360 (1996) DOI ScienceOn |
17 | Wang, W. C., Lu, R. F., Zhao, S. X., and Zhu, Y. Z., Antifertility effect of pseudolaric acid B. Acta. Pharmacol. Sin., 3, 188- 192 (1982) |
18 | Wang, W. C., Lu, R.F., Zhao, S. X., and Gu, Z. P., Comparison of early pregnancy-terminating effect and toxicity between pseudolaric acids A and B. Acta. Pharmacol. Sin., 9, 445-448 (1988) |
19 | Schwartz, D., Almong, N., Peled, A., Goldfinger, N., and Rotter, V., Role of wild-type p53 in the phase: regulation of the - irradiation induced delay and DNA repair. Oncogene, 15, 2597-2607 (1997) DOI ScienceOn |
20 | Hermeking, H., Lengauer, C., Polyak, K., He, T. C., Zhang, L., Thiagalingam, S., Kinzler, K. W., and Vogelstein, B., 14-3-3- Sigma is a p53-regulated inhibitor of /M progression. Mol. Cell, 1, 3-11 (1997) DOI ScienceOn |
21 | Lane, D.P., p53, guardian of the genome. Nature, 258, 15-16 (1992) DOI ScienceOn |